MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer
Published in Gut (IF: 24.5), 2024
Recommended citation: Tang Y*, Tang S*, Yang W, et al. MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer. Gut. Published Online First: 31 August 2024. doi:10.1136/gutjnl-2024-332350 (*co-first author)
Download Paper
